Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPL | P40238 | 12/20 | 0.60 |
| ▸ | CTRC | Q99895 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.54 |
| ▸ | NSD2 | O96028 | 1/20 | 0.53 |
| ▸ | MMP14 | P50281 | 1/20 | 0.53 |
| ▸ | CASP6 | P55212 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.51 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3009730 | 0.83 | CYP1A2 (0.77) | MPLCTRCCYP1A2CYP2C9NSD2 | |
| SCHEMBL3009727 | 0.83 | CYP1A2 (0.77) | MPLCTRCCYP1A2CYP2C9NSD2 | |
| SCHEMBL6250235 | 0.83 | MPL (0.55) | MPLCTRCCYP1A2CYP2C9NSD2 | |
| SCHEMBL16220563 | 0.82 | CYP1A2 (0.79) | MPLCTRCCYP1A2CYP2C9MMP14 | |
| SCHEMBL9343019 | 0.82 | CYP1A2 (0.75) | MPLCTRCCYP1A2CYP2C9NSD2 | |
| SCHEMBL135509 | 0.82 | CYP1A2 (0.75) | MPLCTRCCYP1A2CYP2C9NSD2 | |
| SCHEMBL16034162 | 0.78 | POLB (0.55) | MPLCTRCCYP1A2CYP2C9CYP2D6 | |
| SCHEMBL16034161 | 0.78 | POLB (0.55) | MPLCTRCCYP1A2CYP2C9CYP2D6 | |
| SCHEMBL23259433 | 0.78 | CYP1A2 (0.71) | CYP1A2CYP2C9CYP2D6POLBGAA | |
| SCHEMBL16691181 | 0.78 | CYP1A2 (0.71) | CYP1A2CYP2C9CYP2D6POLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030161849-A1 | Cosmetic and dermatological preparations in the form of O/W emulsions, comprising an amino-substituted hydroxybenzophenone | BASF AKTIENGESELLSCHAFT (DE) | 2003-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030161849-A1 | Cosmetic and dermatological preparations in the form of O/W emulsions, comprising an amino-substituted hydroxybenzophenone | TYR, CUTA, POLR1C | MPL 1232/4885CTRC 4177/4885CYP1A2 239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.